Sofinnova Partners

Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials

Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma

Develops in vivo engineered monocyte immunotherapy to treat solid tumours in preclinical stage